The continuing problem of extrapyramidal symptoms: Strategies for avoidance and effective treatment

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 23, 1999, Pages 20-21

  Gerlach, Jes ^a  

^a Sct Hans Hospital   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

AKATHISIA; ARTICLE; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LONG TERM CARE; PARKINSONISM; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

ADULT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; DIBENZOTHIAZEPINES; DYSTONIA; FEMALE; HUMANS; MALE; MOVEMENT DISORDERS; PARKINSONIAN DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0033402078     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Casey DE. Side effects of new antipsychotic agents. J Clin Psychiatry 1996;57(suppl 11):40-45
2. Adler LA, Angrist B, Reiter S, et al. Neuroleptic-induced akathisia: a review. Psychopharmacology 1989;97:1-11
3. Casey DE, Keepers GA. Neuroleptic side effects: acute extrapyramidal syndromes and tardive dyskinesia. In: Casey DE, Christensen AV, eds. Psychopharmacology: Current Trends. Berlin, Germany: Springer; 1988: 74-93
4. Casey DE. Extrapyramidal syndromes: epidemiology, pathophysiology and the diagnostic dilemma. CNS Drugs 1996;5(suppl 1):1-12
5. Hellewell JSE. Attitudes towards the treatment of schizophrenia and perceptions of antipsychotic side effects: a multinational survey of psychiatrists, nurses, patients and caregivers [abstract]. Presented at the 11th annual congress of the European College of Neuropsychopharmacology; Oct 31-Nov 4, 1998; Paris, France
6. Gerlach J, Peacock L. Intolerance to neuroleptic drugs: the art of avoiding extrapyramidal syndromes. Eur Psychiatry 1995;10(suppl):27S-31S
7. World Health Organization. Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. Br J Psychiatry 1990;156:412-414
8. Collaborative Working Group on Clinical Trial Evaluations. Adverse effects of the atypical antipsychotics. J Clin Psychiatry 1998;59(suppl 12): 17-22
9. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796
10. Fitton A, Heel RC. Clozapine: a review of its pharmacologic properties and therapeutic use in schizophrenia. Drugs 1990;40:722-747
11. Chouinard G, Jones B, Remington G, et al. A Canadian multicenter, placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 1993;13:25-40
12. Jauss M, Schroder J, Pantel J, et al. Severe akathisia during olanzapine treatment of acute schizophrenia. Pharmacopsychiatry 1998;31:146-148
13. Buckley P. New dimensions in the pharmacologic treatment of schizophrenia and related psychoses. J Clin Psychopharmacol 1997;37:363-378
14. Barnes TRE, McPhillips MA. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia. Int Clin Psychopharmacol 1998;13(suppl 3): S49-S57
15. Tollefson GD, Beasley CM, Tamura RN, et al. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Am J Psychiatry 1997;154:1248-1254
16. Arvanitis LA, Miller BG, and the Seroquel Trial 13 Study Group. Multiple fixed doses of Seroquel (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biol Psychiatry 1997;42:233-246
17. Yeung PP, Goldstein JM, Hellewell JSE, et al. Seroquel (quetiapine): extrapyramidal symptoms in general and elderly psychotic patient populations [poster]. Presented at the 11th annual congress of the European College of Neuropsychopharmacology; Oct 31-Nov 4, 1998; Paris, France
18. Meats P. Quetiapine (Seroquel): an effective and well tolerated atypical antipsychotic. Int J Psychiatry Clin Pract 1997;1:231-239
19. Peuskens J, Link CGG. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. Acta Psychiatr Scand 1997;96:265-273
20. Copolov DL, Link CGG, Kowalcyk B. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, Seroquel) and haloperidol in schizophrenia. Psychol Med. In press
21. Hellewell JSE, Kalali AH, Langham SJ, et al. Patient satisfaction and acceptability of long-term treatment with quetiapine. Int J Psychiatry Clin Pract 1999;3:105-113
22. Green B. Quetiapine in the management of treatment-emergent tardive dyskinesia and parkinsonian side effects: a case report. J Clin Psychiatry 1999;60(suppl 23):21
23. Taboada IH. Clinical heterogeneity between atypical antipsychotics in the treatment of schizophrenia: a case report. J Clin Psychiatry 1999;60(suppl 23):23